The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading SCP vendors.John Galt Solutions, with its ...

The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading S&OP vendors.John Galt Solutions, with its ...

The German Olympic body DOSB on Saturday approved the roadmap leading up to a decision on the German Olympics bid at the ...

Leaders who invest in strengthening their decision making muscles not only perform better themselves, but they also unlock ...

Cadence’s Reela Samuel notes that as multi-die integration becomes the new engine of semiconductor performance, the decision ...